OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.36 USD
-0.10 (-6.85%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $1.40 +0.04 (2.94%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OPK 1.36 -0.10(-6.85%)
Will OPK be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for OPK based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for OPK
OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands
Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key Metrics
OPK: What are Zacks experts saying now?
Zacks Private Portfolio Services
OPKO Health (OPK) Q3 Earnings Surpass Estimates
Here's Why You Should Add OPKO Health Stock to Your Portfolio
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Other News for OPK
Fell Below 50 Day Moving Average appears for OPK after 6.85% move
Starbucks, Opko Health, Roblox, Cloudflare, Apple: Trending by Analysts
Jefferies Downgrades OPK: Price Target Lowered by 20% | OPK Stock News
Opko Health’s CEO Makes Bold Move with Major Stock Purchase
Crossed Above 50 Day Moving Average appears for OPK after 2.1% move